Generics 27

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Nilotinib manufacturers

27 products found

Filters

27 products found

nilotinib

Oral solution 50 mg/ml

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam
Manufacturer #21467

This global pharmaceutical company is dedicated to improving patients' lives through high-quality, differentiated products and services. They leverage a collaborative network to achieve success in key regions like the EU and North America. Their focus areas include women's health, infectious diseases, and potentially other therapeutic areas based on their recent approvals and launches. They produce prescription medications (including injectables) and tablets, demonstrating expertise in various dosage forms. The company holds GMP certifications and boasts successful product patents, solidifying its commitment to quality and innovation.

Manufacturer usually replies in 0 days

nilotinib

Capsules 50 mg, 150 mg, 200 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Chile , Vietnam
Manufacturer #519
This pharmaceutical company is a leading manufacturer and exporter with operations spanning over 160 countries, specializing in the development, production, and sale of high-quality generic pharmaceuticals for human use. They have a strong track record of success, having received numerous awards and distinctions including the "European Award for Best Practices" . The company's extensive product portfolio encompasses a wide range of dosage forms and therapy areas, with specific details on these areas, forms, GMP certifications, and patents not provided in the text. Their focus extends beyond prescription medications to include over-the-counter drugs and potentially medical devices or supplements as well.

nilotinib

Capsules 50 mg, 150 mg, 200 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
France , Germany , Gibraltar , Greece , Hungary , Iceland , Ireland , Italy , Isle Of Man , Jersey , Kosovo , Latvia , Liechtenstein , Lithuania , Luxembourg , North Macedonia , Malta , Montenegro , Moldova , Monaco , Netherlands , Norway , Poland , Portugal , Serbia , San Marino , Slovakia , Slovenia , Spain , Svalbard And Jan Mayen , Sweden , Switzerland , Ukraine , United Kingdom , Vatican , Vietnam
Available for
Licensing with supply
Manufacturer #385

A pharmaceutical manufacturer based in the EU that has been active in 60+ countries selling its products in Europe, North America, LATAM, MENA, Africa, and Asia for 60+ years. Key production lines are Rx and nutraceuticals. The company's production lines are EU GMP-compliant.

Manufacturer usually replies in 1 days

Want to see all 27 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

What is the drug Nilotinib?

Nilotinib is a selective tyrosine kinase inhibitor. Nilotinib is medication to treat blood cancer and, more precisely, patients with Philadelphia chromosome-positive chronic myelogenous leukemia. The nilotinib drug is usually used when other treatments have failed; it is to overcome Imatinib when patients are resistant to this drug. Nilotinib is a second-generation tyrosine kinase inhibitor. Due to its rare use, Nilotinib is considered an “orphan medicine.”
Nilotinib medication was approved in 2007 by the FDA and in 2009 by the EU EMA. Nilotinib is on the list of the World Health Organization’s essential medicines.

Nilotinib wholesalers and manufacturers:

Novartis manufactures Nilotinib under the name Tasigna. Novartis is also the marketing authorization holder.
Nilotinib suppliers market it in the form of oral capsules. Nilotinib can be found in capsules of 50 mg, 100 mg, and 200 mg.

Nilotinib for sales:

The retail prices of Nilotinib depend on the dosage of the capsule. In the US, for a 50 mg capsule, Nilotinib costs around $ 137 per unit, it equals to $ 16,470 for 120 capsules. For 150 mg and 200 mg, one Nilotinib capsule costs $ 137, and for 28 capsules, it costs $ 3,850.
Nilotinib is mostly available from the European Union, India, and the United States on the Pipelinepharma B2B marketplace. If you are looking for Nilotinib manufacturers, our online platform will help Nilotinib distributors to connect globally with qualified manufacturers that have been verified through quality control procedures. On Pipelinepharma website, you can find a list of many pharmaceutical products, including Nilotinib. Thanks to our very intuitive website, you can easily place an order for Nilotinib and be in relation with Nilotinib manufacturers.

How to use Nilotinib drug?

Depending on the phase the patient is in, the Nilotinib dosage will be adjusted. For a newly diagnosed patient, the usual dose for an adult is 300 mg taken twice a day. For a resistant patient, the prescription for an adult is 400 mg taken twice a day. In both cases, Nilotinib drugs must be taken orally within 12 hours in between the two doses. It is better to take Nilotinib medication on an empty stomach; it means no food 2 hours before taking the drug and 1 hour after taking it.
Nilotinib medication can have some side effects; the most common ones are nausea, rash, headache, and fatigue. Patients should not take Nilotinib if they are allergic if they have low blood levels of potassium or magnesium or a heart rhythm disorder called long QT syndrome.
It must be stored at room temperature, away from heat, moisture, and direct light.

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible